HEALTHY EXTRACTS INC.: Healthy Extracts Q2 2026 Net Revenue Up 113% to Record $2.1 Million, Driving Adj. EBITDA of $290,000 or $0.02 per Share
Healthy Extracts Inc. (OTCQB:HYEX) reported Q2 2026 net revenue up 113% to a record $2.1 million and adj. EBITDA of $290,000 ($0.02/share). Gross profit rose 145% to $1.5 million, with gross margin up to 70.3%. Results were attributed to the Gummy USA merger and the Imaraïs Beauty acquisition/partnership.
How this was made
The 30-second read
Why it matters
The release combines quarterly financial results with operational milestones (Imaraïs partnership order, shipping to 4,000+ locations, and acquisition into a wholly owned subsidiary), which can influence near-term trading sentiment and expectations for subsequent quarters.
Market read
For HYEX, the key tradable update is the fresh Q2 print with acquisition-linked growth and a stated ambition for annualized revenue above $20M by year end.
What to watch
Net loss remains present in Q2 (-$129k), operating expenses rose 115%, and the $20M annualized target is aspirational rather than confirmed guidance.
Background
Healthy Extracts is an OTCQB nutraceutical formulation and precision-dose gummy manufacturer, recently expanding via Gummy USA merger (Oct 2025) and Imaraïs Beauty acquisition (May 2026).
Ticker impact
Healthy Extracts reports Q2 2026 net revenue up 113% to $2.1M and adj. EBITDA of $290k, citing Gummy USA merger and Imaraïs acquisition.
Likely positive bias for HYEX on follow-through interest, with volatility around whether the $20M annualized revenue goal is credible.
The article provides fresh quarterly financial datapoints and ties them to specific consolidation events (merger and acquisition), which can re-rate growth expectations for a microcap OTC issuer.
Market effects
Highlights ongoing consolidation and B2B retail distribution expansion in nutraceutical gummies and functional wellness.
No clear regional macro linkage beyond the company’s Las Vegas base.
Mentions international retail presence via Imaraïs, but the disclosed impact is primarily US-focused.
Counterpoint
Record revenue growth may be heavily acquisition-driven, so organic demand and repeatability of margins could be weaker than headline growth implies.
Key entities
- companyHealthy Extracts Inc.
Reports Q2 2026 record net revenue and adjusted EBITDA, attributing growth to merger and acquisition integration.
- companyGummy USA
Synergistic merger partner cited as a driver of revenue and margin improvement.
- companyImaraïs Beauty
Acquired operating subsidiary; partnership order of nearly 4 million gummies and distribution into major retailers.
- personSommer Ray
Founder of Imaraïs Beauty, referenced as part of the brand’s market traction.
